Related Experiment Video
Updated: May 18, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Novel strategies to target inflammatory processes in atherosclerosis
Toshio Imanishi1, Takashi Akasaka
1Department of Cardiovascular Medicine, Wakayama, Medical University, 811-1 Kimiidera, Wakayama 641-8510, Japan. t-imani@wakayama-med.ac.jp
Abstract:
Atherosclerosis is characterized by chronic inflammation of the vascular wall. Macrophages, which differentiate from circulating monocytes, give rise to foam cells by excessive accumulation of modified lipoproteins. Atherogenesis subsequently progresses through necrotic core expansion associated with apoptosis and the suppressed clearance of apoptotic macrophage (i.e. efferocytosis), followed by the transition to vulnerable plaques. The vulnerable plaque is characterized by thinning of the fibrous cap and necrotic core expansion. Here, the impact of monocytes/macrophages in both early atherogenesis and advanced plaque progression is discussed with a focus on the potential targeting of inflammatory processes in atherosclerosis.
Related Concept Videos
Atherosclerosis III: Management
Inflammation
Atherosclerosis I: Introduction
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
